When Humira, the powerful biologic which works wonders, came off patent, it took seven years for a biosimilar to come to market. Why? Because of these burdensome, onerous bureaucratic red tape requirements in part at the fda. The fundamental problem in healthcare is that we have non-competitive markets. It's something we don't talk about. It's a sacred cow topic. But the solution is to convert them to competitive markets. We want to see more biosimilars. (14:17–14:23)
CLAIM
Asserts that non-competitive markets are a fundamental problem in healthcare.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.